Thorax 2007, 62: 718–722.CrossRefPubMed 22. Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, Mao L, Wang XS, Martel M, Komaki R, Cox JD, Milas L, Wei Q: Single Nucleotide Polymorphism at rs1982073:T869C of the TGFbeta1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non-Small-Cell Lung Cancer
Treated With Definitive Radiotherapy. J Clin Oncol 2009, in press. 23. Lee SJ, Lee SY, Jeon HS, Park SH, Jang #Selleckchem PF299 randurls[1|1|,|CHEM1|]# JS, Lee GY, Son JW, Kim CH, Lee WK, Kam S, Park RW, Park TI, Kang YM, Kim IS, Jung TH, Park JY: Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2005, 14: 571–575.CrossRefPubMed 24. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M: A model for gastric cancer epidemiology. Lancet 1975, 2: 58–60.CrossRefPubMed 25. Gao L, Nieters A, Brenner H: Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility. Aliment Pharmacol Ther 2008, 28: 565–573.CrossRefPubMed
26. Siegel PM, Massague J: Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003, 3: 807–821.CrossRefPubMed 27. Shu XO, Gao YT, Cai Q, Pierce L, Cai H, Ruan ZX, Yang G, Jin F, Zheng W: Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res 2004, 64: 836–839.CrossRefPubMed selleck screening library 28. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL,
Healey CS, Kemp PR, Luben RN, Chang-Claude J, Mannermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC: A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003, 63: 2610–2615.PubMed 29. Le Marchand L, Haiman Sclareol CA, Berg D, Wilkens LR, Kolonel LN, Henderson BE: T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev 2004, 13: 412–415.PubMed 30. Shin A, Shu XO, Cai Q, Gao YT, Zheng W: Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages. Cancer Epidemiol Biomarkers Prev 2005, 14: 1567–1570.CrossRefPubMed 31. Lundberg M, Pajusto M, Koskinen WJ, Makitie AA, Aaltonen LM, Mattila PS: Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer. Head Neck 2009, 31: 664–672.CrossRefPubMed 32. Castillejo A, Rothman N, Murta-Nascimento C, Malats N, Garcia-Closas M, Gomez-Martinez A, Lloreta J, Tardon A, Serra C, Garcia-Closas R, Chanock S, Silverman DT, Dosemeci M, Kogevinas M, Carrato A, Soto JL, Real FX: TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis. Int J Cancer 2009, 124: 608–613.CrossRefPubMed 33.